Autoantibodies to DEK oncoprotein in a patient with systemic lupus erythematosus and sarcoidosis
about
Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomesThe acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexesThe SAF-box domain of chromatin protein DEKDEK binding to class II MHC Y-box sequences is gene- and allele-specificDissecting the Potential Interplay of DEK Functions in Inflammation and CancerSubcellular localization of the human proto-oncogene protein DEKIntercellular trafficking of the nuclear oncoprotein DEK.Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer.The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions.The DEK nuclear autoantigen is a secreted chemotactic factorExpression level of DEK in chronic lymphocytic leukemia is regulated by fludarabine and Nutlin-3 depending on p53 status.Progress in studies on the DEK protein and its involvement in cellular apoptosis.DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis.DEK proto-oncogene is highly expressed in astrocytic tumors and regulates glioblastoma cell proliferation and apoptosis.A role for intracellular and extracellular DEK in regulating hematopoiesis.Structure-specific binding of the proto-oncogene protein DEK to DNA.Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEKFunctional domains of the ubiquitous chromatin protein DEK.Protein phosphatase 2A activates the HIV-2 promoter through enhancer elements that include the pets site.Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case-Control Study of Patients with Head and Neck Squamous Cell Carcinoma.
P2860
Q24538878-73F1949F-FC80-4F76-9838-D56D5E4CACF7Q24684940-63A27171-4C79-4261-912F-96394C39CEE3Q24791552-0530451C-1153-492C-8DD8-924567F507DDQ24805012-3C36FF9C-7379-4BBE-B09F-B7BE777503B0Q26783559-A1ADE66E-D2CD-4FEC-9961-9B5892068CA2Q28186821-DCB8B404-AC98-432E-96C6-12FE3C2F02B7Q30539239-84CF4FB0-A01D-4B0B-89E2-EE5BDA814E34Q33929637-B6110878-CB64-4D80-8860-2F3C9D9D4598Q34124022-BE219E11-E005-4E94-97A2-EBF3BB1BD292Q35131718-3D37CACD-0A36-4FA7-909A-FA0FF6B97745Q35221391-E83F77F7-1B49-4F0C-B6B5-34D93578102FQ36524257-FE61459C-4854-41D0-A7DB-AB59743D5B83Q37566333-08F56691-833D-4094-8D68-12B5CE68F49FQ37637728-51029138-8317-48F0-B713-3ED79A59BE3CQ38697212-73CE0895-85FD-4AD1-B13C-7294A8DB3C5CQ39184178-1258F681-06B1-4084-A5DA-D277F58E81B6Q40315204-7788902D-0CA8-4CD1-B007-763A42B05743Q41296153-A0A58252-01B0-4639-A96B-FA5E5DB9F60CQ41296165-7342091F-D35C-4B83-B986-6976D66BC7E8Q43586923-2E55653D-5B00-4CF5-84F7-A2B557C383DFQ47242249-1A67B952-27B8-40F4-9690-18411074CB11
P2860
Autoantibodies to DEK oncoprotein in a patient with systemic lupus erythematosus and sarcoidosis
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Autoantibodies to DEK oncoprot ...... erythematosus and sarcoidosis
@ast
Autoantibodies to DEK oncoprot ...... erythematosus and sarcoidosis
@en
Autoantibodies to DEK oncoprot ...... erythematosus and sarcoidosis
@nl
type
label
Autoantibodies to DEK oncoprot ...... erythematosus and sarcoidosis
@ast
Autoantibodies to DEK oncoprot ...... erythematosus and sarcoidosis
@en
Autoantibodies to DEK oncoprot ...... erythematosus and sarcoidosis
@nl
prefLabel
Autoantibodies to DEK oncoprot ...... erythematosus and sarcoidosis
@ast
Autoantibodies to DEK oncoprot ...... erythematosus and sarcoidosis
@en
Autoantibodies to DEK oncoprot ...... erythematosus and sarcoidosis
@nl
P2093
P2860
P1476
Autoantibodies to DEK oncoprot ...... erythematosus and sarcoidosis
@en
P2093
P2860
P304
P356
10.1002/1529-0131(199808)41:8<1505::AID-ART23>3.0.CO;2-N
P407
P577
1998-08-01T00:00:00Z